Skip to content

CTEV CTEV EBITDA

EBITDA at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$10.96M-51.2%
Corvel logo
CorvelCRVL
$47.98M+17.3%
Phreesia logo
PhreesiaPHR
$16.7M+365%
UnitedHealth Group logo
UnitedHealth GroupUNH
ROP
Roper Technologies, Inc.ROP
Cognizant logo
CognizantCTSH

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Calculated from CTEV’s reported figures.

$6.6Mebit+
$111.1MDepreciation Depletion & Amortization
=$117.73M

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's EBITDA?
CTEV (CTEV) reported EBITDA of $117.73M in Q1 2026.
How has CTEV's EBITDA changed year-over-year?
CTEV's EBITDA decreased by 2.1% year-over-year, from $120.26M to $117.73M.
What is the long-term trend for CTEV's EBITDA?
Over 4 years (2021 to 2025), CTEV's EBITDA has grown at a -12.0% compound annual growth rate (CAGR), from $791.22M to $474.3M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.